Proteinase-activated receptor-4 plays a major role in the recruitment of neutrophils induced by trypsin or carrageenan during pleurisy in mice

Pharmacology

Volumn 89, Issue 5-6, 2012, Pages 275-282

  Gomides, L F ^a   Duarte, I D ^a   Ferreira, R G ^a   Perez, A C ^a   Francischi, J N ^a   Klein, A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Neutrophils; Neutrophils recruitment; Pleurisy; Proteinase activated receptor 4

Indexed keywords

2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; APROTININ; CARRAGEENAN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; PEPTIDE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 4; TRYPSIN; TYROSYLPROLYLGLYCYLLYSYLPHENYLALANINE AMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; MOUSE; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PLEURISY; PRIORITY JOURNAL;

ANIMALS; APROTININ; CARRAGEENAN; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; OLIGOPEPTIDES; PLEURISY; RECEPTORS, PROTEINASE-ACTIVATED; TRYPSIN; TRYPSIN INHIBITORS;

EID: 84863752534     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000337378     Document Type: Article

References (36)

1. Faurschou M, Borregaard N: Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317-1327.
2. Korkmaz B, Horwitz MS, Jenne DE, Gau their F: Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62: 726-759.
3. Kobayashi SD, DeLeo FR: Role of neutrophils in innate immunity: a systems biologylevel approach. Wiley Interdiscip Rev Syst Biol Med 2009; 1: 309-333.
4. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
5. Kobayashi Y: The role of chemokines in neutrophil biology. Front Biosci 2008; 13: 2400-2407.
6. Samuelsson B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-575.
7. Hollenberg MD, Compton SJ: International Union of Pharmacology XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002; 54: 203-217.
8. Coughlin SR: Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-1814.
9. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, Andrade-Gordon P: Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol 2002; 169: 1467-1473.
10. Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS, Thompson PJ, Stewart GA: Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E 2release from human respiratory epithelial cells. J Immunol 2002; 168: 3577-3585.
11. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD: Proteinase-activated receptors: transducers of proteinasemediated signaling in inflammation and immune response. Endocr Rev 2005; 26: 1-43.
12. Martin L, Augé C, Boué J, Buresi MC, Chapman K, Asfaha S, Andrade-Gordon P, Steinhoff M, Cenac N, Dietrich G, Vergnolle N: Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 2009; 146: 121-129.
13. Vergnolle N: Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 2009; 123: 292-309.
14. Ramachandran R, Hollenberg MD: Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008; 153(suppl 1):S263-S282.
15. Cottrell GS, Amadesi S, Grady EF, Bunnett NW: Trypsin IV, a novel agonist of proteaseactivated receptors 2 and 4. J Biol Chem 2004; 279: 13532-13539.
16. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, Scarisbrick I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD: Proteinase-activated receptors (PARs), targets for kallikrein signalling. J Biol Chem 2006; 281: 32095-32112.
17. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR: Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819-6823.
18. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, Griffin C, Coughlin SR: Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003; 102: 3224-3231.
19. McDougall JJ, Zhang C, Cellars L, Joubert E, Dixon CM, Vergnolle N: Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis Rheum 2009; 60: 728-737.
20. Houle S, Papez MD, Ferazzini M, Hollenberg MD, Vergnolle N: Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents. Br J Pharmacol 2005; 146: 670-678.
21. Slofstra SH, Bijlsma MF, Groot AP, Reitsma PH, Lindhout T, ten Cate H, Spek CA: Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007; 110: 3176-3182.
22. Braga AD, Miranda JP, Ferreira GM, Bilheiro RP, Duarte ID, Francischi JN, Klein A: Blockade of proteinase-activated receptor-4 inhibits the eosinophil recruitment induced by eotaxin-1 in the pleural cavity of mice. Pharmacology 2010; 86: 224-230.
23. Smith M, Kocher HM, Hunt BJ: Aprotinin in severe acute pancreatitis. Int J Clin Pract 2010; 64: 84-92.
24. Falcone RC, Aharony D: Modulation of ligand binding to leukotriene B 4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents. J Pharmacol Exp Ther 1990; 255: 565-571.
25. Richards IM, Griffin RL, Oostveen JA, Morris J, Wishka DG, Dunn CJ: Effect of the selective leukotriene B 4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am Rev Respir Dis 1989; 140: 1712-1716.
26. Das AM, Flower RJ, Hellewell PG, Teixeira MM, Perretti M: A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br J Pharmacol 1997; 121: 97-104.
27. Klein A, Talvani A, Silva PM, Martins MA, Wells TN, Proudfoot A, Luckacs NW, Teixeira MM: Stem cell factor-induced leukotriene B 4 production cooperates with eotaxin to mediate the recruitment of eosinophilsduring allergic pleurisy in mice. J Immunol 2001; 167: 524-531.
28. Mathieu J, Tissot M, Nolibe D, Florentin I, Kergonou JF, Giroud JP: Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages. Int J Exp Pathol 1990; 71: 603-616.
29. Chen D, Carpenter A, Abrahams J, Chambers RC, Lechler RI, McVey JH, Dorling AJ: Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med 2008; 205: 1739-1746.
30. Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA: Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 2005; 175: 2598-2605.
31. Vergnolle N: Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 1999; 163: 5064-5069.
32. Bolton SJ, McNulty CA, Thomas RJ, Hewitt CR, Wardlaw AJ: Expression of and functional responses to proteinase-activated receptors on human eosinophils. J Leukoc Biol 2003; 74: 60-68.
33. Paszcuk AF, Quintão NL, Fernandes ES, Juliano L, Chapman K, Andrade-Gordon P,Campos MM, Vergnolle N, Calixto JB: Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol 2008; 581: 204-215.
34. Saleh TS, Calixto JB, Medeiros YS: Effects of antiinflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 1999; 20: 949-956.
35. Okuno T, Yokomizo T, Hori T, Miyano M, Shimizu T: Leukotriene B 4 receptor and the function of its helix 8. J Biol Chem 2005; 280: 32049-32052.
36. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T: A G-protein-coupled receptor for leukotriene B 4 that mediates chemotaxis. Nature 1997; 387: 620-624.